chromatec成立于1999年,是一家致力于提供不同的凝血診斷領(lǐng)域人類和重組蛋白的生物技術(shù)公司。此外,chromatec還在蛋白質(zhì)組學(xué)領(lǐng)域提供不同的服務(wù)。chromatec的產(chǎn)品普遍被quan球范圍內(nèi)的大學(xué)、生物技術(shù)公司、制藥公司和研究機(jī)構(gòu)所使用,并通過了DIN EN ISO 9001:2015認(rèn)證。
2. Nguyen T-H, Greinacher A, Delcea M. Quantitative description of thermodynamic and kinetic properties of the platelet factor 4/heparin bonds. Nanoscale. 2015; 7:10130-10139
3. Arman M, Krauel K, Tilley DO, et al. Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4. Blood. 2014;123(20):3166–74.
4. Block S, Greinacher A, Helm CA, et al. Characterization of bonds formed between platelet factor 4 and negatively charged drugs using single molecule force spectroscopy. Soft matter. 2014;10(16):2775–84.
5. Schulze A, Jensch I, Krauel K, et al. New insights in heparin-induced thrombocytopenia by the use of fluid-phase assays to detect specifically platelet factor 4/heparin complex antibodies and antibody-secreting cells. Thrombosis research. 2014;134(1):174–81.
6. Kreimann M, Brandt S, Krauel K, et al. Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4. Blood. 2014;124(15):2442–9.
8. Krauel K, Hackbarth C, Fürll B, et al. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies. Blood. 2012;119(5):1248–55.
10. Kolde H-J, Dostatni R, Mauracher S. Rapid and simple IgG specific test for the exclusion of heparin induced thrombocytopenia (HIT). Clinical Chemistry and Laboratory Medicine. 2011;49(12):2065–8.